Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Stroke
|
June 17, 1998
Diagnosis of stroke by the nonneurologist. A validation study
J M Ferro, A N Pinto, I Falcão, et al.
Schizophrenia Research
|
June 22, 2018
Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
Satyajit Mohite, Salvina M de Campos-Carli, Natalia P Rocha, et al.
Life Sciences
|
December 14, 2002
Effect of electrical stimulation of the baso-lateral amygdala nucleus on defensive burying shock probe test and elevated plus maze in rats
J A Saldívar-González, A Posadas-Andrews, R Rodríguez, et al.
Schizophrenia Research
|
July 22, 2015
Procalcitonin levels in schizophrenic patients and patients with sepsis
Salvina Maria de Campos, Izabela G Barbosa, Rafael Ribeiro-Santos, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 30, 2021
Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls
Rodrigo Ferretjans, Renan P de Souza, Bruna Panizzutti, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
March 1, 2018
Correlation between serum 25-hydroxyvitamin D levels and carotid intima-media thickness in a Brazilian population descended from African slaves
F C Monteiro Júnior, N R Mandarino, E M Santos, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 9, 2020
Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
S Batista, C C Nunes, J J Cerqueira, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 30, 2020
REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
S Batista, C C Nunes, J J Cerqueira, et al.
Schizophrenia Research
|
May 24, 2014
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia
Rodrigo Ferretjans, Salvina Maria de Campos, Rafael Ribeiro-Santos, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Stroke
|
June 17, 1998
Diagnosis of stroke by the nonneurologist. A validation study
J M Ferro, A N Pinto, I Falcão, et al.
Schizophrenia Research
|
June 22, 2018
Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
Satyajit Mohite, Salvina M de Campos-Carli, Natalia P Rocha, et al.
Life Sciences
|
December 14, 2002
Effect of electrical stimulation of the baso-lateral amygdala nucleus on defensive burying shock probe test and elevated plus maze in rats
J A Saldívar-González, A Posadas-Andrews, R Rodríguez, et al.
Schizophrenia Research
|
July 22, 2015
Procalcitonin levels in schizophrenic patients and patients with sepsis
Salvina Maria de Campos, Izabela G Barbosa, Rafael Ribeiro-Santos, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 30, 2021
Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls
Rodrigo Ferretjans, Renan P de Souza, Bruna Panizzutti, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
March 1, 2018
Correlation between serum 25-hydroxyvitamin D levels and carotid intima-media thickness in a Brazilian population descended from African slaves
F C Monteiro Júnior, N R Mandarino, E M Santos, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 9, 2020
Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
S Batista, C C Nunes, J J Cerqueira, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 30, 2020
REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
S Batista, C C Nunes, J J Cerqueira, et al.
Schizophrenia Research
|
May 24, 2014
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia
Rodrigo Ferretjans, Salvina Maria de Campos, Rafael Ribeiro-Santos, et al.
Page
of 6